Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
| ▸ | CES1 | P23141 | 1/20 | 0.30 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.30 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8372675 | 0.75 | ALDH1A1 (0.48) | ALDH1A1TRPA1TSHRKDM4ECES2 | |
| SCHEMBL10055238 | 0.72 | ALDH1A1 (0.38) | ALDH1A1TRPA1TSHRCES2CES1 | |
| SCHEMBL8376185 | 0.70 | TDP1 (0.45) | ALDH1A1TSHRKDM4ECYP4F2CYP4A11 | |
| SCHEMBL22635008 | 0.70 | CYP2A6 (0.38) | ALDH1A1TRPA1TSHRKDM4E | |
| SCHEMBL2692611 | 0.69 | NCEH1 (0.37) | — | |
| SCHEMBL3357562 | 0.69 | TRPA1 (0.39) | ALDH1A1TRPA1TSHRKDM4ECES2 | |
| SCHEMBL30516101 | 0.69 | TRPA1 (0.39) | ALDH1A1TRPA1TSHRKDM4ECES2 | |
| SCHEMBL5353293 | 0.69 | MDM4 (0.36) | ALDH1A1TRPA1TSHRKDM4E | |
| SCHEMBL10759453 | 0.69 | KDM4E (0.46) | KDM4E | |
| SCHEMBL5892854 | 0.68 | TRPA1 (0.35) | ALDH1A1TRPA1TSHRCES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7196225-B2 | Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof | SONY CORPORATION (JP) | 2007-03-27 | — | — | US | disclosed |
| US-7196225-B2 | Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof | SONY CORPORATION (JP) | 2007-03-27 | — | — | US | disclosed |
| US-7196225-B2 | Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof | SONY CORPORATION (JP) | 2007-03-27 | — | — | US | disclosed |
| EP-1090911-B1 | Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof | SONY CORP (JP) | 2006-08-30 | — | — | EP | disclosed |
| US-20060178522-A1 | BIS(AMINOSTYRYL) ANTHRACENE COMPOUND, SYNTHESIS INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF | JOLED INC. (JP) | 2006-08-10 | — | — | US | disclosed |
| US-7049470-B1 | Bis (aminostyryl) anthracene compound, synthesis is intermediate thereof, and process for production thereof | SONY CORPORATION (JP) | 2006-05-23 | — | — | US | disclosed |
| EP-1090911-A2 | Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof | SONY CORPORATION (JP) | 2001-04-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060178522-A1 | BIS(AMINOSTYRYL) ANTHRACENE COMPOUND, SYNTHESIS INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF | AASDHPPT, DDC, AADAT | ALDH1A1 782/4885TRPA1 812/4885TSHR 4248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.